Lorantis' Acquisition

Lorantis was acquired by Celldex Therapeutics on October 12, 2005.

Lorantis is discovering and developing breakthrough products for the treatment of immunological and inflammatory diseases based on antigen-specific tolerance. The company's approach arises from the di…

Articles about Lorantis' Acquisition: